Literature DB >> 20445195

Cerebellar atrophy in human and murine succinic semialdehyde dehydrogenase deficiency.

Maria T Acosta1, Jeeva Munasinghe, Phillip L Pearl, Maneesh Gupta, Andrey Finegersh, K Michael Gibson, William H Theodore.   

Abstract

Human succinic semialdehyde dehydrogenase deficiency, an autosomal recessive disorder of γ-aminobutyric acid (GABA) catabolism, was modeled by a murine model sharing the phenotype of ataxia and seizures. Magnetic resonance imaging (MRI) with volumetry was obtained on 7 patients versus controls, and MRI with stereology was derived in 3 murine genotypes: null, wild-type, and heterozygous mutants. All patients had T1 hypointensity and T2 hyperintensity in globus pallidus, and 5 also had similar changes in subthalamic and cerebellar dentate nuclei. There was a trend for patients to have a smaller cerebellar vermis. Homozygous null mice had significantly lower total brain and cerebellar volumes than wild-types and heterozygotes. Stereology confirmed cerebellar atrophy and was otherwise normal in multiple regions. Cerebellar volume loss is present in the murine disorder with a trend for cerebellar atrophy in patients. Reduced cerebellar volume can reflect neurodegeneration and may be related to the clinical manifestations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20445195      PMCID: PMC3155424          DOI: 10.1177/0883073810368137

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  24 in total

Review 1.  Magnetic resonance spectroscopy of neurotransmitters in human brain.

Authors:  Edward J Novotny; Robert K Fulbright; Phillip L Pearl; K Michael Gibson; Douglas L Rothman
Journal:  Ann Neurol       Date:  2003       Impact factor: 10.422

2.  The efficiency of systematic sampling in stereology and its prediction.

Authors:  H J Gundersen; E B Jensen
Journal:  J Microsc       Date:  1987-09       Impact factor: 1.758

3.  Age and gender effects on microglia and astrocyte numbers in brains of mice.

Authors:  Peter R Mouton; Jeffrey M Long; De-Liang Lei; Victor Howard; Mathias Jucker; Michael E Calhoun; Donald K Ingram
Journal:  Brain Res       Date:  2002-11-22       Impact factor: 3.252

4.  Pharmacologic rescue of lethal seizures in mice deficient in succinate semialdehyde dehydrogenase.

Authors:  B M Hogema; M Gupta; H Senephansiri; T G Burlingame; M Taylor; C Jakobs; R B Schutgens; W Froestl; O C Snead; R Diaz-Arrastia; T Bottiglieri; M Grompe; K M Gibson
Journal:  Nat Genet       Date:  2001-10       Impact factor: 38.330

5.  Clinical, fluorine-18 labeled 2-fluoro-2-deoxyglucose positron emission tomography (FDG PET), MRI of the brain and biochemical observations in a patient with 4-hydroxybutyric aciduria; a progressive neurometabolic disease.

Authors:  M A Al-Essa; S M Bakheet; Z J Patay; J E Powe; P T Ozand
Journal:  Brain Dev       Date:  2000-03       Impact factor: 1.961

6.  Seizure evolution and amino acid imbalances in murine succinate semialdehyde dehydrogenase (SSADH) deficiency.

Authors:  M Gupta; M Polinsky; H Senephansiri; O C Snead; E E W Jansen; C Jakobs; K M Gibson
Journal:  Neurobiol Dis       Date:  2004-08       Impact factor: 5.996

7.  Clinical spectrum of succinic semialdehyde dehydrogenase deficiency.

Authors:  P L Pearl; K M Gibson; M T Acosta; L G Vezina; W H Theodore; M A Rogawski; E J Novotny; A Gropman; J A Conry; G T Berry; M Tuchman
Journal:  Neurology       Date:  2003-05-13       Impact factor: 9.910

8.  Diffusion tensor MRI and fiber tractography of cerebellar atrophy in phenytoin users.

Authors:  Seung-Koo Lee; Susumu Mori; Dong Joon Kim; Sei Young Kim; Si Yeon Kim; Minkyung Chu; Kyoung Heo; Byung In Lee; Dong Ik Kim
Journal:  Epilepsia       Date:  2003-12       Impact factor: 5.864

9.  Proton MR spectroscopy in succinic semialdehyde dehydrogenase deficiency.

Authors:  T Ethofer; U Seeger; U Klose; M Erb; B Kardatzki; E Kraft; G B Landwehrmeyer; W Grodd; A Storch
Journal:  Neurology       Date:  2004-03-23       Impact factor: 9.910

10.  Expression of GABA(B) receptors is altered in brains of subjects with autism.

Authors:  S Hossein Fatemi; Timothy D Folsom; Teri J Reutiman; Paul D Thuras
Journal:  Cerebellum       Date:  2009-03       Impact factor: 3.847

View more
  5 in total

1.  Succinic Semialdehyde Dehydrogenase Deficiency Presenting as Autism Spectrum Disorder.

Authors:  Maria Gogou; Martha Spilioti; Despoina Tramma; Efimia Papadopoulou-Alataki; Athanasios Evangeliou
Journal:  Indian J Pediatr       Date:  2016-01-25       Impact factor: 1.967

2.  Glial localization of antiquitin: implications for pyridoxine-dependent epilepsy.

Authors:  Laura A Jansen; Robert F Hevner; William H Roden; Si Houn Hahn; Sunhee Jung; Sidney M Gospe
Journal:  Ann Neurol       Date:  2014-01-02       Impact factor: 10.422

Review 3.  Succinic semialdehyde dehydrogenase deficiency (SSADHD): Pathophysiological complexity and multifactorial trait associations in a rare monogenic disorder of GABA metabolism.

Authors:  P Malaspina; J-B Roullet; P L Pearl; G R Ainslie; K R Vogel; K M Gibson
Journal:  Neurochem Int       Date:  2016-06-14       Impact factor: 3.921

4.  Magnetic Resonance Imaging (MRI) and Spectroscopy in Succinic Semialdehyde Dehydrogenase Deficiency.

Authors:  Onur Afacan; Edward Yang; Alexander P Lin; Eduardo Coello; Melissa L DiBacco; Phillip L Pearl; Simon K Warfield; Ssadh Deficiency Investigators Consortium
Journal:  J Child Neurol       Date:  2021-02-09       Impact factor: 1.987

5.  Metabolic or Ischemic Stroke in Succinic Semi-aldehyde Dehydrogenase Deficiency Due to the Homozygous Variant c. 1343 + 1_1343 + 3delGTAinsTT in ALDH5A1.

Authors:  Josef Finsterer; Carla A Scorza; Fulvio A Scorza; Ritwik Ghosh
Journal:  Ann Indian Acad Neurol       Date:  2020-06-05       Impact factor: 1.383

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.